**Outlook:**Liminal BioSciences Inc. Common Shares assigned short-term B2 & long-term B1 forecasted stock rating.

**Dominant Strategy :**Sell

**Time series to forecast n: 07 Dec 2022**for (n+8 weeks)

**Methodology :**Modular Neural Network (Market Direction Analysis)

## Abstract

In this paper a Bayesian regularized artificial neural network is proposed as a novel method to forecast financial market behavior. Daily market prices and financial technical indicators are utilized as inputs to predict the one day future closing price of individual stocks. The prediction of stock price movement is generally considered to be a challenging and important task for financial time series analysis. (Güreşen, E. and Kayakutlu, G., 2008, October. Forecasting stock exchange movements using artificial neural network models and hybrid models. In International Conference on Intelligent Information Processing (pp. 129-137). Springer, Boston, MA.)** We evaluate Liminal BioSciences Inc. Common Shares prediction models with Modular Neural Network (Market Direction Analysis) and ElasticNet Regression ^{1,2,3,4} and conclude that the LMNL stock is predictable in the short/long term. **

**According to price forecasts for (n+8 weeks) period: The dominant strategy among neural network is to Sell LMNL stock.**

## Key Points

- Technical Analysis with Algorithmic Trading
- Short/Long Term Stocks
- What are buy sell or hold recommendations?

## LMNL Target Price Prediction Modeling Methodology

We consider Liminal BioSciences Inc. Common Shares Decision Process with Modular Neural Network (Market Direction Analysis) where A is the set of discrete actions of LMNL stock holders, F is the set of discrete states, P : S × F × S → R is the transition probability distribution, R : S × F → R is the reaction function, and γ ∈ [0, 1] is a move factor for expectation.^{1,2,3,4}

F(ElasticNet Regression)

^{5,6,7}= $\begin{array}{cccc}{p}_{\mathrm{a}1}& {p}_{\mathrm{a}2}& \dots & {p}_{1n}\\ & \vdots \\ {p}_{j1}& {p}_{j2}& \dots & {p}_{jn}\\ & \vdots \\ {p}_{k1}& {p}_{k2}& \dots & {p}_{kn}\\ & \vdots \\ {p}_{n1}& {p}_{n2}& \dots & {p}_{nn}\end{array}$ X R(Modular Neural Network (Market Direction Analysis)) X S(n):→ (n+8 weeks) $R=\left(\begin{array}{ccc}1& 0& 0\\ 0& 1& 0\\ 0& 0& 1\end{array}\right)$

n:Time series to forecast

p:Price signals of LMNL stock

j:Nash equilibria (Neural Network)

k:Dominated move

a:Best response for target price

For further technical information as per how our model work we invite you to visit the article below:

How do AC Investment Research machine learning (predictive) algorithms actually work?

## LMNL Stock Forecast (Buy or Sell) for (n+8 weeks)

**Sample Set:**Neural Network

**Stock/Index:**LMNL Liminal BioSciences Inc. Common Shares

**Time series to forecast n: 07 Dec 2022**for (n+8 weeks)

**According to price forecasts for (n+8 weeks) period: The dominant strategy among neural network is to Sell LMNL stock.**

**X axis: *Likelihood%** (The higher the percentage value, the more likely the event will occur.)

**Y axis: *Potential Impact%** (The higher the percentage value, the more likely the price will deviate.)

**Z axis (Yellow to Green): *Technical Analysis%**

## Adjusted IFRS* Prediction Methods for Liminal BioSciences Inc. Common Shares

- Alternatively, the entity may base the assessment on both types of information, ie qualitative factors that are not captured through the internal ratings process and a specific internal rating category at the reporting date, taking into consideration the credit risk characteristics at initial recognition, if both types of information are relevant.
- The business model may be to hold assets to collect contractual cash flows even if the entity sells financial assets when there is an increase in the assets' credit risk. To determine whether there has been an increase in the assets' credit risk, the entity considers reasonable and supportable information, including forward looking information. Irrespective of their frequency and value, sales due to an increase in the assets' credit risk are not inconsistent with a business model whose objective is to hold financial assets to collect contractual cash flows because the credit quality of financial assets is relevant to the entity's ability to collect contractual cash flows. Credit risk management activities that are aimed at minimising potential credit losses due to credit deterioration are integral to such a business model. Selling a financial asset because it no longer meets the credit criteria specified in the entity's documented investment policy is an example of a sale that has occurred due to an increase in credit risk. However, in the absence of such a policy, the entity may demonstrate in other ways that the sale occurred due to an increase in credit risk.
- An entity's estimate of expected credit losses on loan commitments shall be consistent with its expectations of drawdowns on that loan commitment, ie it shall consider the expected portion of the loan commitment that will be drawn down within 12 months of the reporting date when estimating 12-month expected credit losses, and the expected portion of the loan commitment that will be drawn down over the expected life of the loan commitment when estimating lifetime expected credit losses.
- To be eligible for designation as a hedged item, a risk component must be a separately identifiable component of the financial or the non-financial item, and the changes in the cash flows or the fair value of the item attributable to changes in that risk component must be reliably measurable.

*International Financial Reporting Standards (IFRS) are a set of accounting rules for the financial statements of public companies that are intended to make them consistent, transparent, and easily comparable around the world.

## Conclusions

Liminal BioSciences Inc. Common Shares assigned short-term B2 & long-term B1 forecasted stock rating.** We evaluate the prediction models Modular Neural Network (Market Direction Analysis) with ElasticNet Regression ^{1,2,3,4} and conclude that the LMNL stock is predictable in the short/long term.**

**According to price forecasts for (n+8 weeks) period: The dominant strategy among neural network is to Sell LMNL stock.**

### Financial State Forecast for LMNL Liminal BioSciences Inc. Common Shares Options & Futures

Rating | Short-Term | Long-Term Senior |
---|---|---|

Outlook* | B2 | B1 |

Operational Risk | 32 | 37 |

Market Risk | 86 | 35 |

Technical Analysis | 36 | 73 |

Fundamental Analysis | 73 | 58 |

Risk Unsystematic | 51 | 82 |

### Prediction Confidence Score

## References

- Firth JR. 1957. A synopsis of linguistic theory 1930–1955. In Studies in Linguistic Analysis (Special Volume of the Philological Society), ed. JR Firth, pp. 1–32. Oxford, UK: Blackwell
- Christou, C., P. A. V. B. Swamy G. S. Tavlas (1996), "Modelling optimal strategies for the allocation of wealth in multicurrency investments," International Journal of Forecasting, 12, 483–493.
- T. Shardlow and A. Stuart. A perturbation theory for ergodic Markov chains and application to numerical approximations. SIAM journal on numerical analysis, 37(4):1120–1137, 2000
- Chernozhukov V, Escanciano JC, Ichimura H, Newey WK. 2016b. Locally robust semiparametric estimation. arXiv:1608.00033 [math.ST]
- Morris CN. 1983. Parametric empirical Bayes inference: theory and applications. J. Am. Stat. Assoc. 78:47–55
- Chernozhukov V, Newey W, Robins J. 2018c. Double/de-biased machine learning using regularized Riesz representers. arXiv:1802.08667 [stat.ML]
- Bastani H, Bayati M. 2015. Online decision-making with high-dimensional covariates. Work. Pap., Univ. Penn./ Stanford Grad. School Bus., Philadelphia/Stanford, CA

## Frequently Asked Questions

Q: What is the prediction methodology for LMNL stock?A: LMNL stock prediction methodology: We evaluate the prediction models Modular Neural Network (Market Direction Analysis) and ElasticNet Regression

Q: Is LMNL stock a buy or sell?

A: The dominant strategy among neural network is to Sell LMNL Stock.

Q: Is Liminal BioSciences Inc. Common Shares stock a good investment?

A: The consensus rating for Liminal BioSciences Inc. Common Shares is Sell and assigned short-term B2 & long-term B1 forecasted stock rating.

Q: What is the consensus rating of LMNL stock?

A: The consensus rating for LMNL is Sell.

Q: What is the prediction period for LMNL stock?

A: The prediction period for LMNL is (n+8 weeks)